IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.550
-0.110 (-6.63%)
At close: Nov 7, 2025, 4:00 PM EST
1.550
0.00 (0.00%)
After-hours: Nov 7, 2025, 4:16 PM EST
IN8bio Market Cap
IN8bio has a market cap or net worth of $7.04 million as of November 7, 2025. Its market cap has decreased by -54.15% in one year.
Market Cap
7.04M
Enterprise Value
-2.57M
1-Year Change
-54.15%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $7.04M, a decrease of -96.25%. That is a compound annual growth rate of -53.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 7.54M | -59.58% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 251.76B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |